Roman Chicz is Associate Vice President and Global Head, External Research and Development at Sanofi Pasteur, the largest manufacturer of human vaccines. He is based in Cambridge, Massachusetts. In his present role, he leads External R&D activities and coordinates external science and technology evaluations to establish outside collaborations with academia, government institutions, non-government agencies, multi-national pharmaceutical companies and the biotechnology industry. He also supports Corporate Development in due diligence and negotiation activities and the Sanofi, Merial and Genzyme therapeutic units to review innovative technology opportunities of mutual interest and synergistic benefit.
Dr. Chicz has over 20 years of experience translating novel research discoveries and in licensed opportunities into investigational therapeutics and prophylactic vaccines. Before joining Sanofi Pasteur, Dr. Chicz was the founding Chief Scientific Officer and Vice President of R&D at privately held ImmunoBiologics Corporation, a development stage biotechnology company, the Senior Vice President of R&D at Antigenics Inc. (NASDAQ: AGEN), and a co-founder and Vice President of Discovery Research at the privately held clinical stage biotechnology company ZYCOS Inc. (acquired by MGI Pharma). Prior to joining industry, Dr. Chicz held academic appointments at Harvard University, first as a research and teaching fellow and later as a researcher with fully funded grant support. He is a member of the American Association of Immunologists and the American Society for Biochemistry and Molecular Biology and holds numerous patents and publications in peer reviewed journals in the areas of immunology and vaccine research, including HPV and HSV therapeutic vaccines. Dr. Chicz has chaired and served on various NIH external program review panels and participates on journal editorial review boards and as an invited speaker at international meetings and conferences